title: Plasma asymmetric dimethylarginine (ADMA) is associated with retinopathy in type 2 diabetes.
authors: Department of Metabolic Diseases, Jagiellonian University, 15 Kopernika St., 31-501 Krakow, Poland. malecki_malecki@yahoo.com
authors: Maciej T
authors: MT
authors: Malecki
authors: Anetta
authors: A
authors: Undas
authors: Katarzyna
authors: K
authors: Cyganek
authors: Barbara
authors: B
authors: Mirkiewicz-Sieradzka
authors: Pawel
authors: P
authors: Wolkow
authors: Grzegorz
authors: G
authors: Osmenda
authors: Malgorzata
authors: M
authors: Walus-Miarka
authors: Tomasz J
authors: TJ
authors: Guzik
authors: Jacek
authors: J
authors: Sieradzki
mesh_terms: D000368:Aged; D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood / Q000737:chemistry; D015415:Biomarkers / Q000097:blood; D002851:Chromatography, High Pressure Liquid; D003404:Creatinine / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications*; D003930:Diabetic Retinopathy / Q000097:blood*; D006801:Humans; D008875:Middle Aged; D015999:Multivariate Analysis; D009569:Nitric Oxide / Q000502:physiology; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D012044:Regression Analysis
chemical_list: D015415:Biomarkers; C487735:dimethylarginine; D009569:Nitric Oxide; D001120:Arginine; D003404:Creatinine; D019001:Nitric Oxide Synthase